Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 14;8(4):587-596.
doi: 10.3945/an.117.015560. Print 2017 Jul.

A Systematic Review of the Effects of Polyols on Gastrointestinal Health and Irritable Bowel Syndrome

Adrienne Lenhart  1 , William D Chey  2
Affiliations

A Systematic Review of the Effects of Polyols on Gastrointestinal Health and Irritable Bowel Syndrome

Adrienne Lenhart et al. Adv Nutr. .

Abstract

Polyols are sugar alcohols found in certain fruits, vegetables, and sugar-free sweeteners. They make up a component of the diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols, which is gaining popularity in the treatment of patients with irritable bowel syndrome (IBS). We conducted a systematic review to evaluate the effects of polyols on the gastrointestinal tract in healthy men and women and in patients with IBS. Utilizing PubMed, Ovid, and Embase databases, we conducted a search on individual polyols and each of these terms: fermentation, absorption, motility, permeability, and gastrointestinal symptoms. Standard protocols for a systematic review were followed. We found a total of 1823 eligible articles, 79 of which were included in the review. Overall, available work has shown that polyol malabsorption generally occurs in a dose-dependent fashion in healthy individuals, and malabsorption increases when polyols are ingested in combination. However, studies in patients with IBS have shown conflicting results pertaining to polyol malabsorption. Polyol ingestion can lead to intestinal dysmotility in patients with IBS. Regarding the microbiome, moderate doses of polyols have been shown to shift the microbiome toward an increase in bifidobacteria in healthy individuals and may therefore be beneficial as prebiotics. However, data are limited regarding polyols and the microbiome in patients with IBS. Polyols can induce dose-dependent symptoms of flatulence, abdominal discomfort, and laxative effects when consumed by both healthy volunteers and patients with IBS. Further research is needed to better understand the effects of specific polyols on gastrointestinal function, sensation, and the microbiome in health and gastrointestinal disorders such as IBS.

Keywords: artificial sweeteners; disaccharides; fermentable oligosaccharides; microbiome; monosaccharides; motility; polyols; sugar alcohols.

PubMed Disclaimer

Conflict of interest statement

Author disclosures: AL and WDC, no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Factors involved in the pathophysiology and symptomatology of irritable bowel syndrome. Pathophysiology: (A) changes in bile acid concentrations, (B) gut microbiome, (C) changes in intestinal permeability, (D) immune activation, (E) dysmotility, and (F) visceral hypersensitivity. Symptomatology: (1) increased gas production secondary to rapid fermentation of carbohydrates by bacteria in the intestine and (2) increased water retention in the gut secondary to the effects of osmosis.
FIGURE 2
FIGURE 2
Polyol metabolism and fermentation in the colon.
FIGURE 3
FIGURE 3
Chemical structures of polyols.
See this image and copyright information in PMC

References

    1. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012;10:712–21. - PubMed
    1. Ohman L, Simren M.. Pathogenesis of IBS: role of inflammation, immunity and neuroendocrine interactions. Nat Rev Gastroenterol Hepatol 2010;7:163–73. - PubMed
    1. Chang L, Adeyemo M, Karagiannides I, Videlock EJ, Bowe C, Shih W, Presson AP, Yuan PQ, Cortina G, Gong H, et al. Serum and colonic mucosal immune markers in irritable bowel syndrome. Am J Gastroenterol 2012;107:262–72. - PMC - PubMed
    1. Collins SM. A role for the gut microbiota in IBS. Nat Rev Gastroenterol Hepatol 2014;11:497–505. - PubMed
    1. Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc 2006;106:1631–9. - PubMed

Publication types

MeSH terms